After six months from treatment, the mean neutrophil count was 1.94 ± 1.32 (x 109 / ml), the mean hemoglobin was 84.68 ± 18.44 (g / l), the mean platelet count was 53.65 ± 33.62 (x 109 / ml), the total response was 12.9%, the partial response was 67.7%.